Peer Review History
| Original SubmissionNovember 30, 2022 |
|---|
|
PONE-D-22-32953Investigating the origin of subtelomeric and centromeric AT-rich elements in Aspergillus flavusPLOS ONE Dear Dr. Lustig, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. A significant effort must be made so that the data presented is well described. The text and most tables need clarification in several places. Figures need to be of higher resolution for reviewers.Please address all specific points raised by the two reviewers. Please submit your revised manuscript by Feb 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Cecile Fairhead, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This study was funded in part by USDA NCA 58-6054-0-014." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "AJL was funded in part by USDA NCA 58-6054-0-014. Arthur J. Lustig. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.' Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in your Competing Interests section: "I have no competing interest." Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the manuscript entitled “Investigating the origin of subtelomeric and centromeric AT-rich elements in Aspergillus flavus”, the author is looking at AT-rich regions in the genome of several strains and describe different classes depending on their localization, TE content and orientation. This study is a thorough description of all these AT-rich elements and reveal interesting findings that raise some questions about the possible function of these elements. The text is however a bit difficult to read and the poor quality of the figures and tables does not help. First, the different classes of ATEs (from A to J) are not well defined if at all. There should be a clear definition of what characterizes each class in a short text or table. In addition, these classes should be associated with the three classes that are mentioned in the Abstract lines 25-26. Other points to address (in order of text, regardless of importance): - Line 66 : a reference about RIP should be added (Selker, 1987 for instance). Also, RIP is indeed pre-meiotic but there is no clear evidence that it happens during S phase. - Line 80 : “silencer information regulators” is that a common name for proteins involved in position effect? If so, add a reference - Line 92 : Change Plasmodia to Trypanosoma since the reference cited is only about T. brucei - Line 107: “each strain having different size,” of what? - Lines 110-111: “non-centromeric subtelomeric-enriched region” : unnecessarily complicated sentence: “subtelomeric” is enough - Line 124-125: Where are the four strains from? Are the genomes published? - Line 202: Rephrase. RIP mutates the C, the G->A is a consequence of that. - Line 253, the title says “a major fraction” but line 255 it says 29%. Is 29% really a major fraction? - Line 302: “First, related strains were most often located (in 20/24 cases) at allelic positions”, this must be rephrased, the strains are not located on the chromosome… - Same thing line 304-305: “AT insertions had homologs on non-homologous chromosomes in different strains.” - Line 321: “termed subtelomeres, indicated by the red font” where is the red font? - Line 363: “Reanalysis of AT-element size in NRRL 3357 size ranged from 1.9 kb-21.2 kb.” Rephrase. - Line 369: I don’t think that the right conclusion. - Line 431: “RIP activity depends on the local context of the mutated cytosine” Do you mean in general or in Aspergillus? The mutation and methylation are not always context dependent. - Line 427-448: Why didn’t you use something like RIPcal for such analysis? - Line 566: flavus instead of flavis? - Line 618: Neurospora should be italicized Table 5 A: In the “Strain” column, “NRRL” is missing in front of 3357; also what does this column show? I guess it’s the strain from which the gypsy element is from. If so, why on line 9 the homology with NRRL3357 (itself) is not 100% (whereas it is with SU16)? Table 5 A and B: in the legend: “(EP) positions noted in all three strains” I don’t see the coordinates for all 3 strains. Supp table 3 : In columns 3 and 4: what does the fraction mean? E.g line 2, column 3: 4500/1700 Reviewer #2: This ms describes an interesting analysis of variable repeats in the genome of Aspergillus flavus, by comparing different strain sequences. Although the results are discussed in an interesting fashion, the general procedure followed, the classification of repeats, as well as the tables and figures, need clarification. From the M&M, it seems that insertions, ie, variation between strains, were searched, and also AT rich regions in the most complete genomes, whether conserved or not, but it is unclear how the results from these searches were compared to one another and used. Specific points that need to be adressed: In the introduction, it is mentioned that the genome is compact: it would be good to remind its size and the number of protein-coding genes. It would be good also to give the number of chromosomes and sizes. It is shown on figure 1, but never mentioned in the text. In the results, subtelomeres are defined as 100kb regions at end, but surely this makes sense if all chromosomes are roughly the same size and several Mb large? Table 1: even though the general idea comes across, the table is unclear. First column has individual inserts from one strain, and following columns represent whole chromosome sequence from same strain and other strains, or? What do the shaded and unshaded Xs represent in fact? Presence, absence, allelic or only non allelic? In text describing table: “First, related strains were most often located (in 20/24 cases) at allelic positions in non-AT 303 insertions, when compared to either the NRRL 3357 or CA14. “ Please correct this sentence, as it is not the strains which are “located”. Tables 2 A, B, C: The columns containing the information on Gypsy and Mariner is full of “0” and the information is in table 3, so maybe delete the columns in table2. “TAD” is supposedly “TAD1”? Classification of ATEs: “The homologies fell into eleven classes (A-K).” It would be much clearer if a table describing the features of each class was provided. In discussion, “While one of the functions of ATE formation is the protection against the damaging effects of transposition” is unclear. Does the author mean that the RIP mechanism which leads to ATEs , protects against transposition effects? If yes, please state this more clearly. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Investigating the origin of subtelomeric and centromeric AT-rich elements in Aspergillus flavus PONE-D-22-32953R1 Dear Dr. Lustig, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Cecile Fairhead, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-32953R1 Investigating the origin of subtelomeric and centromeric AT-rich elements in Aspergillus flavus Dear Dr. Lustig: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Pr Cecile Fairhead Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .